Who Owns Astrana Health Company?

Who Owns Astrana Health?

Astrana Health's ownership structure is key to understanding its strategic path and operational focus. A major development was its July 2025 acquisition of Prospect Health for $708 million, significantly broadening its market reach and integrating a large provider and member network.

Understanding who holds ownership in Astrana Health is vital for grasping its market influence and decision-making processes.

Astrana Health, Inc., previously known as Apollo Medical Holdings, Inc., was established in 1994. Headquartered in Alhambra, California, the company's founding vision was to offer physician-centric, technology-driven, risk-bearing healthcare management services. In 2024, Astrana Health reported a total revenue of $2.03 billion, a 47% increase from 2023, and managed care for approximately 1.1 million patients, mainly in California. The company's operations are divided into segments such as Care Partners, Care Delivery, and Care Enablement, utilizing a broad network of physicians and ancillary service providers. This evolution includes understanding its Astrana Health BCG Matrix.

Astrana Health, Inc. traces its origins to a physician-led initiative established in 1994. While some accounts suggest a founding in 1985 by Kenneth Sin and Thomas S. Lam, the company officially commenced operations as ApolloMed Hospitalists, a hospitalist service provider, incorporated in California in 2001. The enduring influence of co-founders Dr. Kenneth Sim and Dr. Thomas S. Lam is evident in their continued roles as Executive Chairman of the Board and Vice Chairman, respectively.

Founding Physicians

Astrana Health was established by a group of physicians. Dr. Kenneth Sim and Dr. Thomas S. Lam are recognized as the key co-founders.

Early Operations

The company began its formal operations in 2001 as ApolloMed Hospitalists. Its initial focus was on providing hospitalist services.

Founding Vision

The core of the company's founding vision was a physician-centric approach to healthcare management. This philosophy guided its early development.

Key Leadership

Dr. Kenneth Sim holds the position of Executive Chairman of the Board. Dr. Thomas S. Lam serves as the Vice Chairman of the Board.

Initial Equity Details

Specifics regarding the initial equity split or shareholding percentages at the company's inception are not publicly detailed. Information on early agreements is also limited.

Enduring Influence

The continued presence of the co-founders on the board signifies their ongoing impact on the company's strategic direction and operations.

The foundational philosophy of Astrana Health was deeply rooted in a physician-centric model for healthcare management. This approach aimed to empower medical professionals and streamline patient care delivery. Understanding the Revenue Streams & Business Model of Astrana Health provides further context to the company's operational framework established by its founders.

Complete Astrana Health Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Astrana Health, Inc. has undergone significant ownership evolution, transitioning from its initial public offering (IPO) on NASDAQ, with dates cited as April 9, 1999, or January 13, 2000, to a more recent merger with Astrana Health Management in December 2017, which facilitated its NASDAQ listing. The company's journey also includes trading on the OTC market since 2008.

As of July 25, 2025, Astrana Health's market capitalization stood at $1.07 billion, with its stock trading at $23.27 per share and 46.2 million shares outstanding. The company's ownership structure is heavily influenced by institutional investors, with 414 such entities holding 33,625,048 shares, representing 67.35% of institutional ownership as of July 23, 2025. Key institutional shareholders include BlackRock, Inc., Vanguard Group Inc., State Street Corp, Fmr Llc, and Dimensional Fund Advisors Lp. Insider holdings saw a minor decrease to 4.59% in April 2025, while mutual funds increased their stake to 47.09% during the same period. The company's robust financial performance, with 2024 total revenue reaching $2,034.5 million, a 47% increase from $1,386.7 million in 2023, underscores its attractiveness to investors and suggests a stable, albeit evolving, corporate ownership landscape. The recent acquisition of Prospect Health for $708 million in July 2025 is a significant development that is expected to further shape Astrana Health's strategic direction and its ownership composition.

Key Stakeholder Insights

Understanding who owns Astrana Health is crucial for assessing its corporate governance and future trajectory. The significant presence of institutional investors points to a strong reliance on market confidence.

• Institutional investors hold a substantial majority of Astrana Health's shares.
• Major financial institutions are among the primary shareholders.
• Insider ownership has seen a slight reduction.
• Mutual funds have increased their investment in the company.
• Recent acquisitions may lead to shifts in the ownership structure.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

The board of directors for Astrana Health, Inc. comprises a blend of its founders, key shareholder representatives, and independent members. As of August 3, 2025, the board includes Dr. Kenneth Sim (Co-Founder & Executive Chairman), Dr. Thomas S. Lam (Co-Founder & Vice Chairman), John Chiang, Weili Dai, J. Lorraine Estradas, Mitchell W. Kitayama, Linda Marsh, Matthew Mazdyasni, and David G. Schmidt. Mitchell W. Kitayama holds the position of Lead Independent Director.

The current voting structure of Astrana Health does not indicate the presence of dual-class shares or special voting rights. However, the company's financial reporting acknowledges noncontrolling interests, which represent equity stakes held by third parties in consolidated entities, including certain variable interest entities (VIEs). This suggests that while Astrana Health maintains financial control, typically by holding over 50% of voting rights or being the primary beneficiary of VIEs, other equity holders participate in these consolidated entities. Dr. Kenneth Sim and Dr. Thomas S. Lam, as co-founders, wield considerable influence. Brandon K. Sim, the President and CEO, directly owned 2.88% of the company's shares, valued at $31.03 million, as of August 3, 2025. The board members collectively bring substantial experience, with an average tenure of 6.6 years. There have been no reported proxy battles or significant activist investor campaigns that have notably altered the company's decision-making processes.

Understanding Astrana Health's Corporate Structure

The ownership and governance of Astrana Health are shaped by its board of directors and the company's overall structure. Understanding these elements is key to comprehending Astrana Health ownership.

• The board includes founders and independent directors.
• Noncontrolling interests indicate third-party equity in consolidated entities.
• Founders Dr. Kenneth Sim and Dr. Thomas S. Lam hold significant influence.
• The CEO, Brandon K. Sim, is a substantial shareholder.
• The average board tenure is 6.6 years.

Astrana Health Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Astrana Health has seen significant shifts in its ownership structure over the past few years, driven by strategic acquisitions and share repurchases. These developments reflect the company's growth trajectory and its efforts to consolidate its market position.

The company's ownership trends indicate a growing influence of institutional investors, with a substantial percentage of shares held by these entities as of July 2025. While insider holdings experienced a minor decrease in April 2025, mutual fund ownership saw an increase during the same period. These movements, coupled with strategic leadership additions aimed at enhancing its AI-enabled platform, suggest a proactive approach to expansion and operational efficiency, which may lead to further adjustments in Astrana Health's corporate ownership and shareholder information.

Institutional Investor Growth

As of July 23, 2025, 414 institutional owners held 33,625,048 shares, representing 67.35% of institutional shares, highlighting increased institutional interest in Astrana Health.

Leadership Enhancements

Key leadership appointments in 2025, including a new COO and Chief Data Officer, signal a strategic focus on scaling the company's AI capabilities and value-based care platform.

Strategic Acquisition Impact

The acquisition of Prospect Health for $708 million is poised to significantly boost revenue and expand the provider network, influencing future Astrana Health ownership trends.

Updated Financial Outlook

The company updated its 2025 guidance, projecting total revenue between $3.1 billion and $3.3 billion and adjusted EBITDA between $215 million and $225 million, reflecting recent strategic moves.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE